Completion range

92–98%

Observed diary completion

Real-time QC

< 24h

Issue visibility and escalation

Support reach

120+

Languages for patient engagement

eCOA built for real-world research

Unified eCOA That Patients Finish.

Delve Health combines eCOA, ePRO, real-time quality control, wearable connectivity, and human concierge support to keep patients engaged, reduce missing data, and protect outcome integrity across clinical trials.

QC
ePRO
DIA
SYNC
Delve Health eCOA mobile experience
Compliance execution layer Patients supported. Sites unburdened. Data protected.

Delve Health is not just an eCOA vendor. Delve is the execution infrastructure behind completion, retention, and endpoint-ready data in decentralized, hybrid, and site-based studies.

Electronic Clinical Outcome Assessment (eCOA) is the digital capture of patient-reported, clinician-reported, observer-reported, and performance outcomes in clinical trials. Modern eCOA systems must support decentralized protocols, longitudinal compliance monitoring, multilingual accessibility, device connectivity, and fast intervention when patients fall behind.

Industry reality

Why eCOA datasets fail in real clinical trials

Most eCOA problems are not caused by forms alone. They are caused by execution gaps: missed diaries, fragmented workflows, patient confusion, delayed site response, and no operational layer strong enough to intervene before missing data becomes endpoint risk.

Software can collect data. It does not guarantee it happens.

  • Diary completion often decays as studies extend and patient burden rises.
  • Sites are rarely staffed to chase every missed task, sync issue, or training problem.
  • Hybrid and decentralized models increase operational complexity across visits, devices, and reminders.
  • Delayed visibility into missing data can turn small compliance issues into major protocol and analysis risks.
  • Paper replacement alone does not solve adherence, retention, or endpoint reliability.
30–60% Potential compliance decay risk over longer follow-up when engagement is passive and intervention is delayed.
40% Missing PRO exposure can materially weaken interpretability when studies rely on longitudinal self-reporting.
70%+ Operational complexity can rise substantially when trials combine ePRO, devices, reminders, logistics, and remote support.
<24h Fast visibility into missing or low-quality data is critical if teams want a realistic chance to recover compliance.
Delve model

The Delve Compliance Execution Layer™

Traditional eCOA vendors deploy software. Delve Health combines software, operational intelligence, patient support, and site augmentation to protect completion and retention in the real world.

Real-time compliance monitoring

Delve surfaces missed tasks, delayed entries, device sync gaps, and workflow exceptions while there is still time to intervene.

Human engagement orchestration

Concierge teams step in when reminders are not enough, helping patients complete tasks, troubleshoot devices, and stay on protocol.

Site burden reduction

Sites do not have to become help desks. Delve absorbs operational friction so coordinators can stay focused on study-critical work.

Wearables + ePRO harmonization

Subjective and objective data are brought together to improve context, signal detection, and endpoint sensitivity.

Quality control and deviation prevention

Edit checks, completion visibility, and early escalation reduce downstream reconciliation work and prevent avoidable protocol issues.

Retention-minded study execution

Delve helps maintain participation over time, not just capture the first few entries after enrollment.

Execution stack

The eCOA execution architecture behind cleaner outcome data

This is how Delve turns digital assessments into study infrastructure rather than isolated forms.

1

Outcome capture layer

ePRO, eClinRO, eObsRO, PerfO, images, audio, video, and scheduled assessments across mobile, tablet, web, or provisioned devices.

2

Compliance intelligence layer

Missed tasks, delayed windows, incomplete submissions, device connectivity gaps, and at-risk engagement patterns surfaced in real time.

3

Engagement orchestration layer

Reminders, multilingual outreach, behavioral nudges, and proactive support aligned to protocol requirements and patient needs.

4

Site augmentation layer

Delve helps coordinate troubleshooting, follow-up, and patient support so research sites are not overwhelmed by routine operational issues.

5

Data readiness layer

Configured exports, harmonized data streams, and visibility into completion trends support analysis, oversight, and operational reporting.

6

Endpoint context layer

Wearables and connected devices add objective context to symptom diaries, helping teams interpret how patients feel and how they function.

eCOA built for real-world research

Clinical outcomes weaken when patients miss diaries, devices fail silently, or sites lack the time to manage every operational exception. Delve Health addresses those failure points by combining eCOA, wearables, analytics, and human support into one fit-for-purpose system.

The result is stronger completion, cleaner longitudinal data, and less daily friction for study teams.

  • Multilingual, global-ready eCOA + ePRO workflows
  • Real-time quality control and early deviation detection
  • BYOD or fully provisioned devices with SIM support
  • Wearables + ePRO harmonized into richer endpoint context
  • Concierge support in 120+ languages
Overview of Delve Health eCOA platform for clinical trials

The three pillars of modern eCOA

Strong eCOA is not just digital form delivery. It is the combination of patient-centered experience, protocol-grade rigor, and ongoing support that keeps participation and data quality stable over time.

Patient-centric, multilingual, accessible

Adaptive UX, mobile-first completion, multimedia guidance, and support that respects real patient variability.

Protocol-driven and researcher-controlled

Branching logic, edit checks, scheduling, visit structure, scoring, and version control without engineering delays.

Connected to wearables and human support

Objective signals plus concierge-supported completion create stronger evidence and more recoverable workflows.

Regulatory context

How regulators evaluate eCOA today

Regulatory confidence depends on more than whether a diary is digital. It depends on whether the data are complete, attributable, timely, auditable, and sufficiently controlled to support interpretation of safety, efficacy, and patient experience.

Completeness matters

Missing longitudinal data can weaken endpoint interpretation and reduce confidence in patient-reported conclusions.

Auditability matters

Systems must preserve timing, structure, logic, and traceability in a way that supports inspection readiness.

Operational control matters

Teams need visibility into issues early enough to act, rather than finding problems only during reconciliation.

A flexible, powerful form builder

Build protocol-aligned instruments in minutes without waiting on long custom development cycles. Delve gives study teams a practical authoring environment for digital assessments that still respects rigor, structure, and control.

  • PRO, ClinRO, ObsRO, and PerfO support
  • Branching, scoring, conditional logic, and edit checks
  • Audio, video, image capture, and guided workflows
  • Sequential forms and multi-step task design
  • Visit windows and configurable completion logic
  • Version control aligned to study change management

Delve supports the operational side of execution too, which is where many eCOA programs break down.

Delve Health eCOA form builder for protocol-aligned assessments
Study lifecycle

eCOA across the clinical development lifecycle

eCOA needs differ by phase. Delve supports short-term tolerability, longitudinal symptom tracking, endpoint-sensitive pivotal studies, and post-market evidence collection with one configurable infrastructure.

Phase I

Capture tolerability, safety symptoms, and early patient experience with structured digital workflows and rapid oversight.

Phase II

Track symptom trends, burden patterns, and early efficacy-related outcomes in more dynamic study populations.

Phase III

Protect endpoint integrity with stronger completion, operational consistency, and early visibility into longitudinal risk.

Post-market

Support long-duration follow-up, real-world engagement, and evidence generation beyond traditional visit schedules.

Hybrid studies

Coordinate site visits, remote tasks, devices, reminders, and support workflows without splintering the patient experience.

Decentralized trials

Extend oversight beyond the site with mobile workflows, provisioned devices, multilingual support, and real-time signals.

Subjective + objective data in one place

Wearables provide objective data. ePRO captures subjective experience. Delve Health merges the two to create stronger context around what patients report and how they function between visits.

  • FDA-aligned digital endpoint support
  • Activity, heart rate, HRV, SpO₂, sleep, respiratory, and metabolic signals
  • Correlation with diaries, site forms, ClinRO, and scheduled visits
  • Real-time trends, alerting, and signal-aware follow-up

Better context leads to better oversight, stronger interpretation, and more complete trial evidence.

Wearable and ePRO data integrated within Delve Health

Wearable types supported (optional)

Add objective measures when they improve endpoint sensitivity or help explain patient-reported trends. Delve monitors device health, data flow, and compliance, then escalates with human outreach when needed.

Activity & sleep

Wear time, steps, sleep duration, quality, and circadian patterns.

Cardiovascular

Heart rate, rhythm flags, BP, ECG-related measures where applicable.

Glucose & metabolic

CGM, glucometers, scales, and metabolic tracking workflows.

Respiratory

Spirometry and home monitoring to contextualize symptoms and function.

SpO₂ & physiologic

Oxygen saturation, pulse, and signal trends with quality monitoring.

Sleep labs & home sleep

Sleep staging and longer-term home monitoring where fit for purpose.

Temperature & vitals

Body temperature and vital sign tracking to support safety and context.

Multi-modal sensors

Composite endpoint strategies combining multiple device streams.

Device strategy: fit-for-purpose selection, BYOD or provisioned kits with SIM, and proactive telemetry monitoring. See Wearables & Digital Endpoints →
Therapeutic fit

eCOA considerations by therapeutic area

Outcome collection does not behave the same way across studies. Patient burden, caregiver involvement, symptom volatility, and digital usability all change by indication. Delve supports these differences.

CNS

Cognitive burden, fatigue, variable engagement, and the need for accessible, simplified task design.

Oncology

High-burden protocols, symptom volatility, multiple touchpoints, and retention-sensitive longitudinal tracking.

Rare disease

Small populations, caregiver workflows, high logistical sensitivity, and the need for white-glove operational support.

Cardiovascular

Long-duration follow-up, wear-time stability, physiologic context, and gradual compliance decay risk.

Respiratory

Daily symptom variability, home monitoring, and the value of connecting subjective and objective signals.

Metabolic

CGM, weight, behavior, and durable follow-up make engagement and multi-source data harmonization especially important.

Operational reality

What actually happens when eCOA is deployed

Real studies do not fail because forms exist. They fail because patients forget, devices disconnect, sites get overloaded, and nobody intervenes soon enough. Delve is designed for those moments.

Patients miss tasks for human reasons

Travel, fatigue, low digital comfort, competing priorities, and confusion all affect completion. Delve helps recover participation instead of just recording attrition.

Sites cannot carry infinite operational burden

Coordinators are not meant to troubleshoot every device, chase every diary, and rescue every late entry manually. Delve reduces that burden.

Device and app issues need fast escalation

Battery problems, pairing failures, sync gaps, and provisioning issues can quietly create missing data if there is no live oversight.

Delayed visibility is expensive

When teams only discover missing data late, recovery options narrow and analysis risk rises. Delve is built for earlier intervention.

Where other eCOA vendors stop, humans take over

Software alone does not fix low tech literacy, missed diaries, sync failures, or device confusion. Delve’s Concierge-as-a-Service™ acts as the operational safety net behind completion and retention.

  • Follow-up on missed entries in real time
  • Multilingual patient coaching and troubleshooting
  • Support for sites during high-burden study periods
  • Reduced deviations and improved completion stability
  • Proactive outreach when device or app issues occur

This is not just eCOA software. It is eCOA with execution behind it.

Learn more about Concierge-as-a-Service™ →

Human concierge support for clinical trial patients using Delve Health
Economic impact

The cost of poor eCOA execution

Missing data is not just a data-management problem. It is an economic problem, an operational problem, and sometimes an endpoint problem. The earlier teams address execution risk, the lower the downstream cost.

Protocol stress

Weak completion can force design reconsideration, operational workarounds, or unplanned corrective effort.

Statistical risk

Longitudinal gaps reduce confidence, weaken interpretability, and may erode the value of patient-reported outcomes.

CRO and site rework

Late issue discovery increases follow-up burden, reconciliation activity, and operational spend.

Delay pressure

When outcome data are inconsistent, teams spend more time explaining, cleaning, and compensating for missingness.

Retention drag

Engagement failure can cascade into dropout, especially in long follow-up or high-burden studies.

Lost insight

Even if a study completes, incomplete eCOA can reduce the strength of the story sponsors hoped to tell.

Built to protect completion, retention, and data readiness

Delve combines the pieces that are usually fragmented across vendors: eCOA, ePRO, wearables, analytics, provisioning, and human support. That helps studies move from isolated data collection to operationally protected evidence generation.

92–98% Diary completion range supported by operational follow-up and compliance visibility.
< 24h Real-time QC and escalation workflows help teams act while recovery is still possible.
120+ Language support for broader patient accessibility and global study readiness.
1 platform Assessments, devices, analytics, and support coordinated through one execution model.

Examples of eCOA outcome improvement

Hybrid oncology study

Improved completion stability through concierge follow-up on missed symptom and diary tasks.

Respiratory study

Higher daily symptom adherence through connected monitoring and proactive patient support.

Longitudinal chronic study

Faster data readiness through unified ePRO, devices, and real-time oversight in one workflow.

Category position

Software vendors optimize tools. Delve optimizes outcomes.

The difference is not cosmetic. It changes how studies are designed, supported, monitored, and recovered when reality gets messy.

Traditional software-first model

Deploys digital forms, reminders, and dashboards, but often assumes sites or sponsors will absorb the operational work required to sustain compliance over time.

Delve execution-first model

Builds the digital layer and the human operating layer together, helping teams protect participation, reduce burden, and keep outcome data usable.

What comes next

The next evolution of eCOA

eCOA is moving beyond digital paper replacement. The next generation combines predictive compliance, passive digital signals, adaptive workflows, and richer endpoint context across patient-reported and sensor-derived data.

Predictive compliance modeling

Identifying which patients are most likely to disengage before data loss becomes visible in aggregate reports.

Adaptive task logic

Smarter scheduling and intervention models that respond to burden, missed patterns, and protocol timing.

Multimodal endpoint fusion

Combining symptoms, function, behavior, and physiology into more complete pictures of real patient experience.

Frequently asked questions

Questions sponsors and research teams ask about eCOA

These answers help explain how Delve approaches eCOA, ePRO, wearables, site support, and compliance-critical execution.

What is eCOA in clinical trials?

eCOA is the digital capture of clinical outcome assessments, including ePRO, eClinRO, eObsRO, and PerfO. It replaces paper-based workflows with web, mobile, or provisioned-device data collection.

What is the difference between eCOA and ePRO?

ePRO is one subset of eCOA. eCOA is the broader framework for digital outcome assessment, while ePRO focuses specifically on data reported directly by patients.

Why do eCOA programs often struggle even when the technology looks good?

Because study performance depends on execution. Patients need onboarding, reminders, support, troubleshooting, and follow-up. Sites need relief. Missing data often begins as an operational issue, not a technology issue.

How does Delve Health improve compliance and retention?

Delve combines configurable digital workflows with real-time quality control, wearable integration, multilingual support, and Concierge-as-a-Service™ that follows up when completion starts to fall.

Can Delve support both BYOD and provisioned devices?

Yes. Delve can support bring-your-own-device strategies and provisioned device models, including logistics, SIM-based devices, and fit-for-purpose deployment planning.

Can wearables be integrated with eCOA and ePRO?

Yes. Delve can harmonize wearable and connected-device data with patient-reported outcomes to provide better operational oversight and richer endpoint context.

Which studies benefit most from a compliance-focused eCOA model?

Longitudinal, high-burden, decentralized, hybrid, rare disease, CNS, oncology, cardiometabolic, and respiratory studies often benefit the most because execution complexity is higher.

Does Delve reduce burden on sites?

Yes. Delve is designed to absorb routine patient support, missed-task follow-up, and device troubleshooting so site teams can stay focused on clinical and protocol-critical responsibilities.

Related learning

Build topical authority around eCOA

These linked knowledge pages help support ranking, AI retrieval, and buyer education. Create them and link them from this page.

What is eCOA in clinical trials?

Create a knowledge page that defines eCOA, core modalities, and why digital outcome capture matters.

Suggested page →

eCOA vs ePRO vs DHT

Clarify the differences between patient-reported outcomes, broader eCOA, and device-driven digital health technologies.

Suggested page →

Why eCOA datasets fail

Go deeper on missing data, site burden, patient disengagement, and operational recovery strategies.

Suggested page →

How to choose an eCOA vendor

Outline what sponsors should evaluate, including execution support, quality control, and endpoint readiness.

Suggested page →

Build an eCOA strategy around completion, not just forms

If your study depends on patient-reported data, execution matters. Delve helps sponsors, CROs, and sites protect compliance, reduce burden, and generate cleaner evidence.

Talk to Delve Health